Quidel Corporation

Structural Bioinformatics Inc.

Jason J Sun

Jason McClure

Venkatachalapathi Yalamoori

Darryl Rideout

Kalyanaraman Ramnarayan

Mark Shenderovich

Jian Hua Zheng

Christina Niemeyer

Embodiments of the present disclosure relate to chimeric antibodies which specifically bind todecorin-binding protein A (DbpA) antigens and compositions or kits comprising such antibodies. The disclosure further relates to use of such antibodies in the detection ofsp. in samples, e.g., biological samples such as human blood and/or tissues of deer, ticks and other carriers of. Embodiments of the disclosure further relate to diagnosis and/or therapy of Lyme disease using the chimeric antibodies and/or compositions containing the chimeric antibodies.

DbpA antibodies and uses thereof

Methods and compositions that act as specific inhibitors of ALF activity for the prophylaxis and treatment of anthrax infections.

Inhibitors of anthrax lethal factor activity

Growing community of inventors

San Diego, CA, United States of America

Jason J Sun